Intragastric balloon treatment of obesity: Long-term results and patient satisfaction

Abstract

Background/Aims: Intragastric balloon (IGB) treatment of obesity is a minimally invasive outpatient procedure that has been shown to help weight loss in some patients. The aim of this study is to analyze the long-term results regarding the effectiveness, tolerability, and patient satisfaction in a cohort of patients undergoing the IGB insertion.<o:p></o:p>
Materials and Methods: Using a retrospective cohort study design, patients who had their IGB inserted/removed between the years 2009 and 2016 were contacted by phone and asked to answer a short questionnaire. The baseline characteristics, pre- and post- IGB weight, as well as their current weight were recorded. Different parameters of satisfaction were noted in addition to whether patients resorted to alternative weight-reduction measures.<o:p></o:p>

Results: Ninety-nine eligible patients were contacted, and 65 consented to the study. The average weight loss achieved at the end of the treatment period (3 to 10 months) was approximately a 12% decrease from the baseline. Only 39% of patients were satisfied with the procedure, and less than 50% were satisfied with the weight loss achieved. When assessing the long-term follow-up, years after the IGB removal (3.3±1.76 years), the vast majority of patients (78.7%) regained weight or resorted to further bariatric measures.<o:p></o:p>

Conclusion: IGB leads to weight loss among most patients, but it does not appear to fulfill patients’ expectations. Further, the initial weight loss is not sustainable over time.<o:p></o:p>

Cite this article as: El Haddad A, Rammal MO, Soweid A, et al. Intragastric balloon treatment of obesity: Long-term results and patient satisfaction. Turk J Gastroenterol 2019; 30(5): 461-6.<o:p></o:p>